IRIS
CHITI, ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7319
EU - Europa 713
AF - Africa 350
AS - Asia 244
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 4
Totale 8654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7153
NG - Nigeria 350
CA - Canada 162
FR - Francia 159
IT - Italia 149
NL - Olanda 110
DE - Germania 104
TR - Turchia 80
GB - Regno Unito 77
CN - Cina 55
BE - Belgio 49
IL - Israele 47
FI - Finlandia 33
HK - Hong Kong 12
IR - Iran 12
SG - Singapore 11
IN - India 10
CL - Cile 8
EU - Europa 8
JP - Giappone 5
AT - Austria 4
AU - Australia 4
BR - Brasile 4
ES - Italia 4
PA - Panama 4
RU - Federazione Russa 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
RO - Romania 3
TH - Thailandia 3
UA - Ucraina 3
BD - Bangladesh 2
GR - Grecia 2
NO - Norvegia 2
PL - Polonia 2
SE - Svezia 2
TW - Taiwan 2
AL - Albania 1
AR - Argentina 1
EE - Estonia 1
KR - Corea 1
MD - Moldavia 1
SA - Arabia Saudita 1
Totale 8654
Salva come PNG Salva come JPEG
Città #
Wilmington 2017
Chandler 1722
San Mateo 779
Ann Arbor 613
Leawood 403
Benin City 350
Lawrence 329
Princeton 329
Fairfield 198
Woodbridge 182
Toronto 159
Paris 156
Boardman 112
Amsterdam 105
Kocaeli 80
London 72
Milan 60
Seattle 60
San Diego 58
Norwalk 51
Brussels 49
Monmouth Junction 44
Helsinki 33
Beijing 30
Falls Church 30
Houston 15
Redmond 15
Redwood City 14
Hanover 13
Ashburn 12
Cambridge 11
Des Moines 10
Berlin 9
Singapore 8
Terracina 8
Abbiategrasso 7
Andover 7
Zhengzhou 6
Augusta 5
Florence 5
Jacksonville 5
Chengdu 4
Mumbai 4
Sacramento 4
San Jose 4
Clearwater 3
Frankfurt am Main 3
Hebei 3
Osimo 3
Phoenix 3
Pozzuoli 3
Saint Paul 3
Apo 2
Avigliano 2
Bangkok 2
Buffalo 2
Chongqing 2
Guangzhou 2
Gurgaon 2
Hangzhou 2
Issiglio 2
Rotterdam 2
Saint Louis 2
Santa Clara 2
Sherbrooke 2
Valencia 2
Vienna 2
Alcamo 1
Ardabil 1
Athens 1
Bergamo 1
Changchun 1
Chisinau 1
Dalmine 1
Den Haag 1
Ferrara 1
Ferrara di Monte Baldo 1
Freiburg 1
Gerenzano 1
Henderson 1
La Canada Flintridge 1
Las Vegas 1
Leninsk-kuznetskiy 1
Logan 1
Meieki 1
Monza 1
Nagold 1
Nanchang 1
Nancy 1
Nanjing 1
New Delhi 1
New York 1
Ningbo 1
Novokuznetsk 1
Oslo 1
Philadelphia 1
Raleigh 1
Salzburg 1
Seoul 1
Seriate 1
Totale 8271
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 66
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 58
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 58
11Cl-choline PET/CT in imaging locally advanced prostate cancer 52
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 49
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 47
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 46
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 45
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail 43
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 43
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy 43
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 43
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS 43
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 43
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 41
Evaluation of response: is F-18-FDG PET the answer? 40
INDIUM-111-DTPA-OCTREOTIDE SCINTIGRAPHY MODULATION BY TREATMENT WITH UNLABELED SOMATOSTATIN ANALOG IN SMALL-CELL LUNG-CANCER 40
C-11-Methionine uptake in secondary brain epilepsy 40
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 40
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 40
EANM procedure guideline for treatment of refractory metastatic bone pain 39
Radiopharmaceuticals for breast cancer imaging 39
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can positron emission tomography (PET) with F-18-FDG be considered as the best method? 39
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine 39
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 39
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 39
Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors 39
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 38
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 38
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 38
Pretransplantation pet as major prognostic discriminant in IGEV-treated patients with refractory/relapsed Hodgkin's lymphoma (HL) 38
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 38
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 37
Exploration of Disease Markers under Translational Medicine Model 37
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572-83 37
Primary diagnosis of prostate cancer: potential role of Ga-68-Prostate Specific Membrane Antigen PET/CT 37
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 36
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 36
A risk management approach for imaging biomarker-driven clinical trials in oncology 36
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 36
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 36
FDG PET/CT predictive role in follicular lymphoma 35
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 35
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 35
Multimodal Characterization of Supratentorial Gliomas: Relationship Among Morphological, Metabolic and Molecular features 35
Consensus on molecular imaging and theranostics in prostate cancer 35
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning 35
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 35
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 35
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT 34
Introduction to EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 34
New Clinical Indications for F-18/C-11-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature 34
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 34
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy 34
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma 34
The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors | [La scintigrafia dei recettori per la somatostatina nei tumori neuroendocrini gastro-entero-pancreatici.] 33
A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET) 33
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 33
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 33
A method to reduce acetonitrile amount in F-18-FDG synthesis 33
Absorbed dose from daily routine practice in a nuclear cardiology laboratory 33
Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis 33
PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool? 32
Delayed effect of streptokinase on left ventricular function after acute myocardial infarction assessed by equilibrium gated radionuclide angiocardiography 32
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians 32
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings 32
Nuclear medicine imaging of neuroendocrine tumours 32
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014 32
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 32
Prone scintimammography in patients with non-palpable breast lesions 32
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 32
PET/CT with C-11-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data 32
Nuclear medicine procedures in lung cancer 31
Reply to comment on Pepe et al.: Somatostatin receptor SPECT 31
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 31
Myeloid neoplasms after chemotherapy and PRRT: myth and reality 31
Breaking an unhelpful circle, where innovation and regularia delay clinical practice for patient benefit 31
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 31
F-18-DOPA PET/CT in Neuroblastoma Comparison of Conventional Imaging With CT/MR 31
Standardization and quantification in PET/CT imaging: tracers beyond FDG. 31
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines 31
EANM procedure guidelines for I-131-meta-iodobenzylguanidine (I-131-mIBG) therapy 31
Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group 31
Prognostic significance of molecular and imaging biomarkers in primary brain tumors 31
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [F-18]fluorodeoxyglucose 31
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 31
Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 1-Statement of the Issue and a Review of Available Resources 31
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 31
CASE-REPORT - TECHNETIUM-99M-HEXAKIS-2-METHOXY-ISOBUTYL-ISONITRILE IMAGING OF BREAST-CANCER AND MYOCARDIAL-INFARCTION IN THE SAME PATIENT 31
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 31
C-11-labeled methionine and evaluation of malignant pleural mesothelioma 30
Shaping our future 30
Cardiac and Acoustic Metastases in Relapsing Melanoma 30
PRELIMINARY-RESULTS OF PREOPERATIVE AXILLARY RADIOIMMUNOSCINTIGRAPHY WITH IN-111 B72.3 IN BREAST-CANCER 30
Why New Journals? The Growth of the EJNMMI Family 30
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 30
LUNG UPTAKE OF TL-201 IN MYOCARDIAL STRESS IMAGING - CORRELATION WITH ECHOCARDIOGRAPHIC AND SCINTIGRAPHIC VARIABLES OF MYOCARDIAL-ISCHEMIA 30
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 30
Dementia with Lewy bodies with supranuclear gaze palsy: a matter of diagnosis 30
Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer 30
Totale 3604
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0000 00 00 00020
2020/20213910 38514517 371235 546280 73950438380
2021/20221926 1611762417 3728 73260 16312948891
2022/20232924 752197464566 458467 200 0000
Totale 8780